Effects of antiplatelet and calcium antagonist drugs on infarct size in rats.
The authors performed the experimental model of infarct-like myocardial lesions in rats treated with large doses of ISP. Myocardial necrosis was assessed on the basis of serum enzyme changes as well as of gross and microscopic findings. The infarct size was measured by a direct enzymatic method assaying creatine kinase (CK) depletion in infarcted myocardium. Pretreatment of the infarcted rats with antiplatelet (Lysin Acetyl Salicylate) or calcium antagonist drugs (Verapamil or Nifedipine) allowed the reduction of the necrotic area. Since a smaller size of infarct was achieved through different types of interventions it should be suggested that ISP-myocardial damage is due to several effects of the drug involving metabolic, vascular and/or coagulative patterns.
D000208:Acute Disease; D000818:Animals; D001241:Aspirin / Q000031:analogs & derivatives / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects*; D002118:Calcium / Q000037:antagonists & inhibitors*; D003402:Creatine Kinase / Q000378:metabolism; D007545:Isoproterenol / Q000494:pharmacology; D008239:Lysine / Q000031:analogs & derivatives / Q000494:pharmacology; D008297:Male; D009203:Myocardial Infarction / Q000473:pathology*; D009543:Nifedipine / Q000494:pharmacology; D010974:Platelet Aggregation; D051381:Rats; D014700:Verapamil / Q000494:pharmacology
D014700:Verapamil; D003402:Creatine Kinase; D009543:Nifedipine; D008239:Lysine; D007545:Isoproterenol; D001241:Aspirin; D002118:Calcium; C010395:acetylsalicylic acid lysinate